Trial ID or NCT#
The hypothesis of this study is that focal treatment with ExAblate MRgFUS has the potential to be an effective non-invasive treatment for intermediate risk, organ-confined prostate lesions, with a low incidence of morbidity. The study hypothesis will be tested by measuring treatment-related safety and initial effectiveness parameters in the ExAblate MRgFUS treated patients, as described above.
Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions
Contact us to find out if this trial is right for you.